Domov › Poklici › Bioengineers and Biomedical Engineers › Menlo Park, CA
Bioengineers and Biomedical Engineers v Menlo Park, CA: plače H-1B
20 vlog za delovne pogoje za ta poklic z delovnim mestom v Menlo Park, CA. Medianna osnovna plača $137.034; srednja polovica $113.871–$158.189.
Po plačilnem razredu
| Raven plače | Mediana plače |
|---|---|
| Stopnja I (začetna) | $103.771 |
| Stopnja II (kvalificirana) | $106.691 |
| Stopnja III (izkušena) | $136.852 |
| Stopnja IV (polno usposobljena) | $164.151 |
Department of Labor določi štiri stopnje prevladujočih plač za vsak poklic in območje, od Stopnje I (začetna) do Stopnje IV (popolna usposobljenost). Delodajalec izbere stopnjo, ki ustreza zahtevam delovnega mesta.
Delodajalci
| Delodajalec | LCA | Mediana plače |
|---|---|---|
| Pacific Biosciences of California, Inc. | 4 | $137.034 |
| Ge Precision Healthcare LLC | 3 | $173.000 |
| Talis Biomedical Corporation | 2 | $102.232 |
| GRAIL, Inc. | 2 | $113.168 |
| ReCode Therapeutics, Inc. | 2 | $139.204 |
| Danisco US Inc. | 1 | $100.651 |
| LevitasBio, Inc. | 1 | $161.756 |
| Spark NS, Inc. | 1 | $115.000 |
| Sight Sciences, Inc. | 1 | $166.546 |
| Adialante LLC | 1 | $150.000 |
| Evalve, Inc. | 1 | $156.270 |
| BillionToOne, Inc. | 1 | $103.771 |
Nazivi delovnih mest
- System Engineer II2
- Senior Staff Engineer, Instrument NPI1
- Scientist II R&D1
- Automation Engineer 21
- Lead MR Imaging Scientist, Artificial Intelligence1
- Scientist II1
- Engineer II1
- Process Engineer 21
- Sr. Fluidic System Engineer1
- Senior Director, Formulations and Process Development1
- Project Manager1
- Senior Scientist, Biochemistry1
- Senior Scientist1
- Scientist, Cardiac MR1
- Senior Quality Assurance Engineer1
Sponzorji H-1B v Menlo Park, CA →
Plače so spodnja meja ponujene plače pri vsaki vlogi, pretvorjene v letni znesek; statistika uporablja samo potrjene vloge za polni delovni čas. LCA ni odobritev vizuma, ena LCA pa lahko pokriva več delovnih mest. Vir: U.S. Department of Labor, OFLC LCA Disclosure Data, davčna leta 2023–2026 (najnovejša odločitev 30. jun. 2026).